Centessa Pharmaceuticals (CNTA) Shares Issued (2021 - 2026)

Centessa Pharmaceuticals (CNTA) has 6 years of Shares Issued data on file, last reported at $34.1 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $34.1 million, up 458.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.4 million (up 199.27% YoY), and the FY2025 annual result was $21.4 million, up 90.27% from the prior year.
• Shares Issued rose to $34.1 million in Q1 2026 per CNTA's latest filing, from $14.3 million in the prior quarter.
• Over five years, Shares Issued peaked at $34.1 million in Q1 2026 and troughed at -$2.6 million in Q2 2025.
• A 5-year average of $4.2 million and a median of $568500.0 in 2022 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2024 and 2025: Shares Issued jumped 6583.33% in 2024, then plunged 429.3% in 2025.
• A 5-year view of Shares Issued shows it stood at -$629000.0 in 2022, then surged by 118.76% to $118000.0 in 2023, then surged by 4427.12% to $5.3 million in 2024, then soared by 168.29% to $14.3 million in 2025, then jumped by 138.08% to $34.1 million in 2026.
• Business Quant data shows CNTA's Shares Issued at $34.1 million in Q1 2026, $14.3 million in Q4 2025, and $3.6 million in Q3 2025.